Market Insight

Jun 20, 2022

The rising cost of medication development has put pressure on R&D organizations to contribute to greater efficiency in developing novel drugs. In recent years, the pharmaceutical industry has made tremendous efforts to solve these issues and improve the efficiency of the drug development process. Indubitably, s...

Jul 10, 2018

Aug 09, 2017

Genetically engineered salmon has reached the dinner table, as AquaBounty Technologies, a Massachusetts company has successfully developed and commercialized a genetic variant of salmon fish, Salmo salar. The company announced that it has sold some 4.5 tonnes of its hotly debated product to customers in Canada. This...

Apr 28, 2017

Urinary Incontinence is a multifactorial syndrome which occurs due to the failure of the storage function of the lower urinary tract and loss of bladder control resulting in leakage of urine.  Embarrassment, isolation, and depression are observed among patients with urinary incontinence. Millions of individuals worl...

Apr 10, 2017

Gigantism is excessive production of Growth Hormone (GH) in children which is extremely rare and leads to exaggerated bone growth and an abnormal increase in height. It results from high linear growth due to excessive action of insulin-like growth factor I (IGF-I) while the epiphyseal growth plates are open during c...

Dec 28, 2016

Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disease. The disease has a highly variable course and prognosis. The term lupus has been used to identify a number of chronic, autoimmune diseases that can damage any part of the body (such as skin, joints, and/or organs inside the body). Common symptoms in...

Jan 06, 2015

Gene Therapy: The “Big Value” Market! Gene therapy has been under scientific research for over 2 decades, but viable therapies have yet to gain commercial acceptance due to safety and delivery-related issues. However, Pfizer’s move and some other recent developments in the industry suggest that the therapy may be ...